Singapore-based life sciences ecosystem builder Esco Group is investing Rmb100 million ($15 million) into a new manufacturing and innovation complex in China, with the aim of serving the rapidly growing Chinese market and address unmet needs for Chinese patients.
The Esco Jiangsu Innovation Center, located in Taicang, Suzhou, Jiangsu, just 50 kilometers away from central Shanghai, will be a platform for acceleration and commercialization of life sciences, medical devices, reproductive medicine, and precision medicine technologies, the company said.
